Revolution Medicines Inc (RVMD) valuation history
$188.72
Latest weekly close · Market cap $39.8B
Share RVMD EV/Sales history
Revolution Medicines' EV/Sales is unavailable because recent financial data is missing (as of ).
- No P/E: earnings over the last twelve months are negative.
- No P/S: recent financial data is missing.
- No EV/EBITDA: recent financial data is missing.
No EV/Sales chart for RVMD right now
EV/Sales
n/mnot ranked
No EV/Sales rank: recent financial data is missing.
Growth, last 12 months vs the year before
- Revenue
- n/m
- EPS
- n/m
Price vs revenue and EPS, indexed to 100
Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.
PriceRevenue, last 12 months100 = first reading
EV/Sales at each year-end
The last weekly reading of each year, and its percentile against the five years before it.
| Year-end | EV/Sales | 5-year percentile |
|---|---|---|
| n/m | Too little history | |
| n/m | Too little history | |
| 88.6× | 97 | |
| 46.2× | Too little history |
Loading peers and related research…
About this history
- What is RVMD's current EV/Sales?
- Revolution Medicines' EV/Sales is unavailable because recent financial data is missing (as of Oct 29, 2026).
- What is RVMD's five-year median EV/Sales?
- 49.4x. Half of RVMD's weekly readings since August 2022 were higher and half were lower. This page has 221 weekly readings, from Aug 8, 2022 to Oct 26, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank compares RVMD only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.